Food and Drug Administration, Understanding Investigational Drugs , April 2, 2019 GoodRx, Retatrutide for Weight Loss: Availability, Dosage, and More , June 25, 2026 Food and Drug Administration, Expanded Access, accessed June 29, 2026 Eli Lilly, Expanded Access | Compassionate Use | Clinical Trials , accessed June 29, 2026 WBUR | Here & Now, An extraordinary new obesity drug is still awaiting FDA approval
If your question isn't here, don't worry, Ask our experts for clarity on your journey
Biomolecules 11 (12), 1834
Exenatide, MedlinePlus (2021) Dulaglutide, MedlinePlus (2023) Obesity in adolescents, The New England Journal of Medicine (2023) Nutrition and pubertal development, Indian Journal of Endocrinology and Metabolism (2014) GLP-1 receptor agonists and eating disorders, National Eating Disorder Association (n.d.) Facts about falls, Centers for Disease Control and Prevention (2024) Hypoglycemia in older people a less well recognized risk factor for frailty, Aging and Disease (2015) Ozempic, Novo Nordisk Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
GLP-1 Medications GLP-1 medications have changed the conversation around weight management and type 2 diabetes